ArticleJournal of cutaneous pathology2019

NRAS Q61R and BRAF G466A mutations in atypical melanocytic lesions newly arising in advanced melanoma patients treated with vemurafenib.

Vishwas Parekh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.